The global oral clinical nutrition market size was exhibited at USD 15.9 billion in 2022 and is projected to hit around USD 16.73 billion by 2032, growing at a CAGR of 5.2% during the forecast period 2023 to 2032.
Key Pointers:
- By stage, the adult segment held the largest share of 87.11% in 2022.
- By Indication, the cancer care segment held the largest share of 15.35% in 2022.
- By Sales channel, the institutional sales segment held the largest share of 42.8% in 2022.
- In 2022, North America dominated the oral clinical nutrition market with a share of 30.9%.
Oral Clinical Nutrition Market Report Scope
The Oral clinical nutrition are the supplements such electrolytes, protein, fibre, energy, vitamins and minerals essential for the people with nutrient deficiency. This is due to poor appetite, low food intake and illness. These nutritional products are available in the form of powder, liquid, pudding, fiber, dessert, juices, yogurt and so on which can be consumed orally. They also have a wide range of applications in the treatment of chronic diseases such as cancer, neurological conditions and gastrointestinal disorders.
The key market players are involved in the novel product launch contributing to the global market growth. For instance, in April 2018, Abbott launched a beverage Ensure Protein Max with 2 for people over age 50+ having protein deficiency. The beverage contains 30g protein with 150 calories and 9 amino acids and available in two flavors. The beverage is supplemented with 1g sugar and 22 vitamins and minerals such as Vitamin D, C, and E. Such novel product launch by market players is expected to propel market growth.
Dominant market players are also engaged in collaborations, mergers, acquisitions to enhance the product portfolio and improvise the nutrition portfolio of the company and study the clinical nutrition analysis. This has a positive impact on the global market. For instance, in January 2018, Filament BioSolutions, Inc. entered into a strategic collaboration with CHEO, Ottawa and Ottawa University for a project designed to analyze and study the clinical application of microme-based precision nutrition in IBD. The project was funded by CIHR and Genome Canada.
Moreover, there is rising awareness among people regarding a healthy lifestyle, and consumption of a nutritious diet for improving the body's immunity and living a healthy and fit life. Along with this, there is a rising prevalence of chronic diseases such as cancer. According to the research, loss of appetite, and malnutrition is observed due to the side effects of the clinical treatment. Due to this, the researchers are engaged in formulating oral clinical nutrition supplements by enhancing their nutritional value to counter the side effects of the clinical treatment. This helps in the overall growth of the market. The government and private organizations are investing and raising funds to cater to the problems of malnutrition by improving the R&D and healthcare sector. For instance, in September 2022, Biden-Harris Administration held a White House Conference on Hunger, Nutrition and Health in America to solve the issues of food and proper diet related to nutrient deficiency due to diseases such as diabetes, hypertension, and obesity. The conference stated that over USD 4 billion will be invested by the government in the food nutrition industry to improve the nutritional content in the food and promote a healthy living. Such initiative has led to the development of more advanced and effective oral clinical nutrition supplements, which has increased their adoption and growth in the market.
Further, the COVID-19 pandemic has had a positive impact on the oral clinical nutrition market. The demand for oral clinical nutrition supplements has increased catering to the issues faced due to malnutrition. In order to improve the body's immunity, people have started consuming nutritious food, and supplements enriched with vitamins, fibers, and proteins. Moreover, these supplements are easy to consume. Thus, the global sale of these products has increased in recent years. Market players have also started enhancing the manufacturing capabilities of the food and nutrition departments to cater to the growing demand for quality and regulatory-certified food supplements.
Some of the prominent players in the Oral Clinical Nutrition Market include:
- Abbott Laboratories
- Pfizer Inc.
- Bayer AG
- Nestle S.A.
- GlaxoSmithKline plc
- Baxter International Inc.
- Otsuka Holdings Co., Ltd.
- Mead Johnson & Company, LLC
- Danone Nutricia, Victus, Inc.
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Oral Clinical Nutrition market.
By Stage
By Indication
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
By Sales Channel
- Online Sales
- Retail Sales
- Institutional Sales
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
- Frequently Asked Questions
Request Customization
Get a Sample
Get a Sample
Request Customization